U.S. Panel Approves First Obesity Drug in a Decade

Dec. 8, 2010
About one third of Americans are obese, and the only FDA-approved prescription diet pill on the market is Switzerland-based Roche Holding AG's Xenical, which was approved by the FDA in 1999.

An advisory panel to the US Food and Drug Administration on Dec. 7 gave its approval to an anti-obesity drug, in what could be the first new approved drug for losing weight in more than a decade.

Contrave, a drug developed by the California-based Orexigen Therapies, was given the nod by a 13-7 vote by the FDA expert panel, which advises the regulatory body.

The FDA usually follows its recommendations, and is expected to make a final decision in January.

The panel said the drug was only modestly effective and was found to cause slight boosts in blood pressure and pulse. It also urged a wider trial to assess potential heart attack risks.

The FDA earlier this year acted on the panel's recommendations and denied two new obesity drugs, Qnexa and Lorcaserin, over cancer and heart risks.

The same agency in October requested Abbott Laboratories pull its obesity drug Meridia from the U.S. market after European tests found the key ingredient increased the risk of serious heart problems.

About one third of Americans are obese, and the only FDA-approved prescription diet pill on the market is Switzerland-based Roche Holding AG's Xenical, which was approved by the FDA in 1999.

Copyright Agence France-Presse, 2010

Popular Sponsored Recommendations

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

You Cannot Stay Competitive by Bolting New Technologies to a Legacy ERP

Oct. 20, 2023
Read this white paper to understand the benefits of shifting to a next-generation ERP system as part of a DOP.

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Food and Beverage 2024 Trends and Outlook for North America

Oct. 29, 2023
Ready to hear what 200 of your peers said are the top challenges and opportunities in 2024? Don’t fall behind. Uncover actionable insights to better prepare for 2024 in this whitepaper...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!